Breast cancer elderly women Cancer Research Campaign trial treatment tamoxifen optimal surgery tamoxifen Elderly Breast Cancer Working Party eighty-one women operable breast cancer years mg tamoxifen daily optimal surgery median follow-up months demonstrable difference survival rate quality life treatment groups patients tamoxifen subsequent change management operation local treatment failure progression surgery disadvantageous study Informed consent randomization difficult exclusion eligible patients non-randomized patients total cohort study 